WASHINGTON - Language to establish a pathway for approving follow-on biologics will be incorporated into a comprehensive FDA bill advancing through the Senate, the "Food and Drug Administration Revitalization Act," Sen. Edward Kennedy (D-Mass.) said late Wednesday. (BioWorld Today)